FDA issues convalescent plasma treatment update, new webpage
The Food and Drug Administration yesterday encouraged those who have recovered from COVID-19 to donate plasma for the creation of convalescent plasma, an antibody-rich investigational therapy that may help others fight the disease. The agency also launched a web resource to help guide recovered COVID-19 patients to local blood- or plasma-collection centers.
Related News Articles
Headline
The AHA provided recommendations to the Food and Drug Administration today in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…